title: Synthesis and anti-influenza virus activity of novel pyrimidine derivatives.
abstract: Efficient synthetic routes of 2-amino-4-(omega-hydroxyalkylamino)pyrimidine derivatives were investigated in relation to the anti-influenza virus activity of these compounds. The derivatives in which cyclobutyl and cyclopentyl groups were introduced to the beta-position of the aminoalkyl group (especially the cyclobutyl group substituted by a phenylalkyl group at the 3'-position) resulted in improved antiviral potency: i.e. an average 50% effective concentration for inhibition of plaque formation (EC50, microM) of 0.1-0.01 microM for both types A and B influenza virus. The antiviral efficacies were in the order of amino group > hydroxyiminomethyl group > halogen substitution at the 5-position, and chlorine or methoxy group > hydrogen at the 6-position of the pyrimidine ring. The antiviral indices of these compounds were 2-6 with respect to the 50% inhibitory concentration for cell proliferation (IC50, microM) for growing cells, but > 500 to > 10(4) with respect to the IC50 for stationary cells, indicating that these compounds may be efficacious for the topical treatment of influenza virus infection.
authors.affiliation: Institute for Drug Development, Nesco Company, AZWELL Inc., Ibaragi, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Hisaki
authors.forename: H
authors.initials: H
authors.lastname: Imabori
authors.forename: M
authors.initials: M
authors.lastname: Azuma
authors.forename: T
authors.initials: T
authors.lastname: Suzutani
authors.forename: F
authors.initials: F
authors.lastname: Iwakura
authors.forename: Y
authors.initials: Y
authors.lastname: Ohta
authors.forename: K
authors.initials: K
authors.lastname: Kawanishi
authors.forename: Y
authors.initials: Y
authors.lastname: Ichigobara
authors.forename: M
authors.initials: M
authors.lastname: Node
authors.forename: K
authors.initials: K
authors.lastname: Nishide
authors.forename: I
authors.initials: I
authors.lastname: Yoshida
authors.forename: M
authors.initials: M
authors.lastname: Ogasawara
mesh_terms: D000818:Animals; D000998:Antiviral Agents / Q000138:chemical synthesis / Q000494:pharmacology*; D002460:Cell Line; D006801:Humans; D020128:Inhibitory Concentration 50; D008826:Microbial Sensitivity Tests; D009975:Orthomyxoviridae / Q000187:drug effects*; D011743:Pyrimidines / Q000138:chemical synthesis / Q000494:pharmacology*; D013329:Structure-Activity Relationship
chemical_list: D000998:Antiviral Agents; D011743:Pyrimidines